4549 Stock Overview
Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics and equipment in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Eiken Chemical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,025.00 |
| 52 Week High | JP¥2,055.00 |
| 52 Week Low | JP¥1,334.00 |
| Beta | 0.17 |
| 1 Month Change | 2.74% |
| 3 Month Change | 14.54% |
| 1 Year Change | 30.81% |
| 3 Year Change | -8.12% |
| 5 Year Change | 1.25% |
| Change since IPO | 116.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4549 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 2.8% | 3.6% | 1.8% |
| 1Y | 30.8% | 15.9% | 31.0% |
Return vs Industry: 4549 exceeded the JP Medical Equipment industry which returned 15.9% over the past year.
Return vs Market: 4549 matched the JP Market which returned 31% over the past year.
Price Volatility
| 4549 volatility | |
|---|---|
| 4549 Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 4.1% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 4549 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4549's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1939 | 754 | Tsugunori Notomi | www.eiken.co.jp |
Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics and equipment in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum.
Eiken Chemical Co., Ltd. Fundamentals Summary
| 4549 fundamental statistics | |
|---|---|
| Market cap | JP¥72.09b |
| Earnings (TTM) | JP¥2.95b |
| Revenue (TTM) | JP¥39.90b |
24.5x
P/E Ratio1.8x
P/S RatioIs 4549 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4549 income statement (TTM) | |
|---|---|
| Revenue | JP¥39.90b |
| Cost of Revenue | JP¥22.88b |
| Gross Profit | JP¥17.03b |
| Other Expenses | JP¥14.08b |
| Earnings | JP¥2.95b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 82.76 |
| Gross Margin | 42.67% |
| Net Profit Margin | 7.38% |
| Debt/Equity Ratio | 6.0% |
How did 4549 perform over the long term?
See historical performance and comparison